132 related articles for article (PubMed ID: 6528087)
1. FAC + BCG as adjuvant therapy in breast cancer: an 8-year update.
Blumenschein GR; Buzdar AU; Hortobagyi GN
Recent Results Cancer Res; 1984; 96():129-32. PubMed ID: 6528087
[No Abstract] [Full Text] [Related]
2. Significance of drug dose, timing and radiotherapy in adjuvant therapy of breast cancer.
Buzdar AU; Smith TL; Marcus CE; Hortobagyi GN; Blumenschein GR
Recent Results Cancer Res; 1984; 96():141-7. PubMed ID: 6396767
[No Abstract] [Full Text] [Related]
3. Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer: 8 year results.
Senn HJ; Jungi WF; Amgwerd R; Hochuli E; Ammann J; Engelhart G; Heinz C; Wick A; Enderlin F; Creux G
Recent Results Cancer Res; 1984; 96():90-101. PubMed ID: 6528092
[No Abstract] [Full Text] [Related]
4. Adjuvant systemic therapy in postoperative node-positive patients with breast carcinoma: the CALGB trial and the ECOG premenopausal trial.
Tormey C
Recent Results Cancer Res; 1984; 96():155-65. PubMed ID: 6396769
[No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial.
Buzdar AU; Blumenschein GR; Smith TL; Powell KC; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Ames FC; Martin RG
Cancer; 1984 Feb; 53(3):384-9. PubMed ID: 6362814
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD
Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780
[No Abstract] [Full Text] [Related]
7. Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984).
Jones SE; Brooks RJ; Takasugi BJ; Garewal HS; Giordano GF; Ketchel SJ; Jackson R; Heusinkveld RS; Kemmer SR; Moon TE
Recent Results Cancer Res; 1984; 96():133-40. PubMed ID: 6396766
[No Abstract] [Full Text] [Related]
8. The use of a natural history data base to compare outcome among several trials of adjuvant chemotherapy for stage II breast cancer.
Jones SE; Moon TE
Recent Results Cancer Res; 1984; 96():148-54. PubMed ID: 6396768
[No Abstract] [Full Text] [Related]
9. Clinical trials referral resource. Adjuvant therapy of breast cancer.
Cheson BD
Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
[No Abstract] [Full Text] [Related]
10. Adjuvant therapy of breast cancer: a Southwest Oncology Group experience.
Rivkin SE; Glucksberg H; Foulkes M
Recent Results Cancer Res; 1984; 96():166-74. PubMed ID: 6396770
[No Abstract] [Full Text] [Related]
11. The management of locally advanced breast cancer: a combined modality approach.
Kantarjian HM; Hortobagyi GN; Smith TL; Blumenschein GR; Montague E; Buzdar AU; Martin RG
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1353-61. PubMed ID: 6548710
[TBL] [Abstract][Full Text] [Related]
12. [Present state of the multidisciplinary treatment of locoregionally advanced breast cancer].
Izuo M; Iino Y
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1153-9. PubMed ID: 3840541
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of paclitaxel and carboplatin versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as a neoadjuvant therapy in patients with inoperable breast cancer.
Akhtar MS; Kousar F; Masood M; Fatimi S; Kokab
J Coll Physicians Surg Pak; 2010 Nov; 20(11):748-52. PubMed ID: 21078249
[TBL] [Abstract][Full Text] [Related]
14. CMF adjuvant programs at the Milan Cancer Institute.
Bonadonna G; Rossi A; Tancini G; Valagussa P; Veronesi U
Recent Results Cancer Res; 1984; 96():66-73. PubMed ID: 6549356
[No Abstract] [Full Text] [Related]
15. Results of adjuvant chemotherapy trials in breast cancer at M. D. Anderson Hospital and Tumor Institute.
Buzdar AU; Hortobagyi GN; Marcus CE; Smith TL; Martin R; Gehan EA
NCI Monogr; 1986; (1):81-5. PubMed ID: 3534594
[TBL] [Abstract][Full Text] [Related]
16. Management of inflammatory carcinoma of the breast. A combined modality approach.
Fastenberg NA; Martin RG; Buzdar AU; Hortobagyi GN; Montague ED; Blumenschein GR; Jessup JM
Am J Clin Oncol; 1985 Apr; 8(2):134-41. PubMed ID: 3841746
[TBL] [Abstract][Full Text] [Related]
17. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.
Martín M; Ruiz A; Ruiz Borrego M; Barnadas A; González S; Calvo L; Margelí Vila M; Antón A; Rodríguez-Lescure A; Seguí-Palmer MA; Muñoz-Mateu M; Dorca Ribugent J; López-Vega JM; Jara C; Espinosa E; Mendiola Fernández C; Andrés R; Ribelles N; Plazaola A; Sánchez-Rovira P; Salvador Bofill J; Crespo C; Carabantes FJ; Servitja S; Chacón JI; Rodríguez CA; Hernando B; Álvarez I; Carrasco E; Lluch A
J Clin Oncol; 2013 Jul; 31(20):2593-9. PubMed ID: 23733779
[TBL] [Abstract][Full Text] [Related]
18. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy.
Hortobagyi GN; Spanos W; Montague ED; Buzdar AU; Yap HY; Blumenschein GR
Int J Radiat Oncol Biol Phys; 1983 May; 9(5):643-50. PubMed ID: 6343312
[TBL] [Abstract][Full Text] [Related]
19. Role of adjuvant chemotherapy in male breast cancer.
Patel HZ; Buzdar AU; Hortobagyi GN
Cancer; 1989 Oct; 64(8):1583-5. PubMed ID: 2676137
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory breast cancer: 10-year follow-up of a trial of surgery, chemotherapy, and allogeneic tumor cell/BCG immunotherapy.
Wiseman CL
Cancer Invest; 1995; 13(3):267-71. PubMed ID: 7743378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]